← Eichor
Condition: Primary Mitochondrial Myopathies Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Primary Mitochondrial Myopathies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History in Primary Mitochondrial Myopathies
Phase N/A · 1 location(s) · Cristina Domínguez González · NCT05653544Systemic Biomarkers of Brain Injury From Hyperammonemia
Phase N/A · 1 location(s) · Children's National Research Institute · NCT04602325Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Phase 2 · 55 location(s) · Pharming Technologies B.V. · NCT05650229Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency
Phase 2 · 1 location(s) · Cristina Domínguez González · NCT06754098Natural History Study of Mitochondrial Myopathy
Phase N/A · 1 location(s) · Children's Hospital of Philadelphia · NCT05250375Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
NA · 1 location(s) · University of Missouri-Columbia · NCT07478172Applying pGz in Mitochondrial Disease
Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT05569122Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Phase 3 · 10 location(s) · Khondrion BV · NCT06451757
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.